Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine

被引：2
|
作者：
Cohn, David E. [1 ]
Backes, Floor J. [1 ]
Wallbillich, John J. [1 ]
Bixel, Kristin [1 ]
Crafton, Sarah M. [1 ]
Neff, Robert [1 ]
ElNaggar, Adam C. [1 ]
Smith, Blair [1 ]
Suarez, Adrian A. [2 ]
机构：
[1] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 144卷 / 03期
关键词：
MUTATIONAL ANALYSIS; PERITONEAL CANCER; BORDERLINE TUMORS; CLINICAL BEHAVIOR; 2-TIER SYSTEM; CARCINOMA; THERAPY; STRATEGY; SURVIVAL; DISEASE;
D O I：
10.1016/j.ygyno.2017.01.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A 20 year old with recurrent low-grade serous carcinoma (LGSC) is discussed. The differential diagnosis, pathology, epidemiology, treatment options are discussed. Focus on the molecular pathways of LGSC and the implications of the diagnosis on fertility are highlighted. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码：451 / 455
页数：5
相关论文
共 50 条
  • [41] Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report
    Silva, R.
    Moran, B.
    Das, S.
    Mulligan, N.
    Doughty, M.
    Treacy, A.
    Sheahan, K.
    Kelly, C. M.
    Duffy, A. G.
    Perry, A. S.
    Brennan, D. J.
    CASE REPORTS IN WOMENS HEALTH, 2022, 34
  • [42] Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
    Manning-Geist, Beryl L.
    Gordhandas, Sushmita B.
    Giri, Dilip D.
    Iasonos, Alexia
    Zhou, Qin
    Girshman, Jeffrey
    O'Cearbhaill, Roisin E.
    Zamarin, Dmitriy
    Lichtman, Stuart M.
    Sabbatini, Paul J.
    Tew, William P.
    Li, Karen
    McDonnell, Autumn S.
    Aviki, Emeline M.
    Chi, Dennis S.
    Aghajanian, Carol A.
    Grisham, Rachel N.
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : 12 - 17
  • [43] Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?
    Onoprienko, Arina
    Bartl, Thomas
    Grimm, Christoph
    Concin, Nicole
    Polterauer, Stephan
    CANCERS, 2024, 16 (19)
  • [44] Efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
    Grisham, Rachel
    Aghajanian, Carol
    Van Nieuwenhuysen, Els
    Rodrigues, Manuel
    Ring, Kari
    Santin, Alessandro
    Colombo, Nicoletta
    Prendergast, Emily
    Thaker, Premal
    Moore, Kathleen
    Salinas, Erin
    Ray-Coquard, Isabelle
    Chon, Hye Sook
    Rose, Peter
    Oaknin, Ana
    Clamp, Andrew
    Gandhi, Mitul
    Monk, Bradley
    Holloway, Robert
    Van Gorp, Toon
    Fabbro, Michel
    Gennigens, Christine
    Wojtynek, Nicholas
    Lustgarten, Stephanie
    Banerjee, Susana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A3 - A4
  • [45] Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience
    Dalton, Heather J.
    Fleming, Nicole D.
    Sun, Charlotte C.
    Bhosale, Priya
    Schmeler, Kathleen M.
    Gershenson, David M.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (01) : 37 - 40
  • [46] Phase II study of enzalutamide in androgen receptor positive (AR plus ) recurrent high-grade and low-grade serous ovarian cancer
    Grisham, R. N.
    Giri, D. D.
    McDonnell, A.
    Iasonos, A.
    Zhou, Q.
    Li, K.
    Girshman, J.
    O'Cearbhaill, R. E.
    Zamarin, D.
    Aghajanian, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 23 - 23
  • [47] Clinical behavior of low grade serous ovarian carcinoma: An analysis of 714 patients from the Ovarian Cancer Association Consortium (OCAC)
    May, T.
    Lheureux, S.
    Bernardini, M. Q.
    Jiang, H.
    Tone, A. A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 14 - 14
  • [48] CLINICAL OUTCOMES OF LOW GRADE SEROUS OVARIAN CARCINOMA: A TWENTY FIVE YEAR RETROSPECTIVE CASE SERIES OF THE ROYAL MARSDEN EXPERIENCE
    Lima, J.
    Mclachlan, J.
    della Peppa, C.
    Nobbenhuis, M.
    Gore, M.
    Kaye, S.
    Banerjee, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1420 - 1421
  • [49] Recurrence of low-grade serous ovarian cancer successfully treated with Gemcitabine and Bevacizumab: a case report and literature review
    Sato, Hanako
    Kotani, Yasushi
    Miyagawa, Chiho
    Yahata, Tamaki
    Murakami, Kosuke
    Nakai, Hidekatsu
    Otani, Tomoyuki
    Matsumura, Noriomi
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (05) : 107 - 111
  • [50] Durable response to hormonal therapy in a patient with rapidly progressive low-grade serous ovarian cancer: A case report
    Watson, Catherine H.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY REPORTS, 2020, 33
12345